The FDA has said it will wait for additional results from last week’s trial showing an increased risk of cardiac side effects with Pfizer’s arthritis blockbuster Xeljanz before deciding on
3 Monkeys Zeno has appointed Avril Lee to the newly-created role of head of healthcare for the UK and Europe, as part of the UK agency's plans to strengthen its international health capabil
Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed by childhood epilepsy drug Epidiolex.
Spanish drugmaker Almirall has lined up its new CEO following the departure of Peter Guenter, who left to lead Merck KGaA’s healthcare unit earlier this month.
UK health comms agency Bedrock Healthcare Communications has announced that Chris Barton has joined as strategic solutions director, taking a place on the senior management team.
In our final video from ESMO 2024, web editor Nicole Raleigh spoke with Dr Meredith McKean, a melanoma investigator at the Sarah Cannon Research Institute.